サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：尿失禁の世界市場レポート 2024年
市場調査レポート
商品コード
1415693

尿失禁の世界市場レポート 2024年

Urinary Incontinence Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
尿失禁の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

尿失禁市場規模は近年力強く成長しています。2023年の116億1,000万米ドルから2024年には125億2,000万米ドルへ、CAGR7.8％で成長します。実績期間の成長は、人口の高齢化、尿失禁の認知度、尿失禁の普及率の上昇、ヘルスケアへのアクセスの増加、可処分所得の上昇に起因しています。

尿失禁市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.6％で161億9,000万米ドルに成長します。予測期間の成長は、併存疾患の有病率の増加、ライフスタイル要因、人口健康戦略、ヘルスケア支出の増加に起因しています。予測期間の主な動向には、医療の進歩、革新的技術、非侵襲的治療、デジタルヘルスとmヘルス、革新的な製品設計、患者中心のケアなどがあります。

泌尿器科疾患の有病率の増加は、近い将来、尿失禁市場の拡大に大きな推進力を与えることになるでしょう。泌尿器科疾患には、腎臓、膀胱、尿管、尿道、前立腺、精巣などの重要な構成部位を含む泌尿器系および男性生殖器に影響を及ぼすさまざまな病状が含まれます。尿失禁のような状態に特に重点を置いた泌尿器系疾患の有病率の急増は、これらのヘルスケア上の懸念に対処するために設計された製品や治療オプションの需要を促進しています。泌尿器科疾患に対する認識や診断の高まりは、医療ソリューションやヘルスケア・インフラの継続的な発展とともに、この市場の成長をさらに後押ししています。例えば、米国がん協会（American Cancer Society Inc.）が報告した2023年1月の最新データによると、米国における泌尿器膀胱がんの推定症例数は2023年には82,290例に達し、2020年に記録された81,400例から1.1％増加しています。このことは、主に泌尿器科疾患の罹患率の増加によって、尿失禁市場の拡大の勢いが増していることを裏付けています。

低侵襲手術に対する需要の高まりは、当面の尿失禁市場成長の原動力になると予測されます。低侵襲手術は、手術中に必要な切開の大きさや量を減らすために、特殊な器具や高度な技術の利用を伴う手術手技や介入を包含します。このような低侵襲手技に対する需要の高まりは、尿失禁の管理において重要な役割を果たしており、効果的で患者に優しい治療アプローチを提供しています。患者やヘルスケアプロバイダーは、患者の日常生活や全体的な幸福への影響を最小限に抑えながら症状に対処するために、こうした方法を選択するようになってきています。例えば、2023年1月現在、米国のロボット製品メーカーであるIntuitive Surgical Inc.の報告によると、2022年には約187万5,000件の外科手術がVinci Surgical Systemsを使用して行われました。これは、2021年にVinci Surgical Systemsを使用して行われた約1,594,000件の手術と比較すると、18%増という驚異的な伸びを反映しています。したがって、低侵襲手術に対する需要の高まりは、尿失禁市場の成長を支える重要な原動力になると考えられます。

2023年の尿失禁市場で最大の地域は北米でした。尿失禁レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の尿失禁市場、種類別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 切迫性失禁
  • 腹圧性尿失禁
  • 溢流性失禁
  • 機能性失禁
  • 世界の尿失禁市場、治療タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬剤
  • デバイス
  • その他
  • 世界の尿失禁市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の尿失禁市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 身体検査
  • パッドテスト
  • 尿力学検査
  • 膀胱鏡検査
  • ストレステスト
  • 超音波
  • 尿サンプル
  • 世界の尿失禁市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • 材料ケア
  • その他

第7章 地域および国の分析

  • 世界の尿失禁市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の尿失禁市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 尿失禁市場の競合情勢
  • 尿失禁市場の企業プロファイル
    • Cardinal Health Inc.
    • Johnson and Johnson
    • Medtronic plc
    • Eli Lilly and Company
    • Asahi Kasei Corporation

第31章 その他の主要および革新的な企業

  • Becton Dickinson and Company (C.R. Bard Inc.)
  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Inc.
  • Boston Scientific Corporation
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • Domtar Corporation
  • Cook Medical Inc.
  • Aurobindo Pharma Ltd
  • Coloplast AIS
  • Teleflex Incorporated
  • Apotex Inc.
  • Zydus Lifesciences Limited
  • ConvaTec Group PLC
  • Cook Group Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12292

“Urinary Incontinence Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urinary incontinence market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for urinary incontinence? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The urinary incontinence market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Urge Incontinence; Stress Incontinence; Overflow Incontinence; Functional Incontinence
  • 2) By Treatment Type: Medication; Devices; Other Treatments
  • 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administrations
  • 4) By Diagnosis: Physical Exam; Pad Test; Urodynamic Testing; Cystoscopy; Stress Test; Ultrasound; Urine Samples
  • 5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson; Medtronic plc; Eli Lilly and Company; Asahi Kasei Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Urinary incontinence is a medical condition characterized by the involuntary loss of urine, which can range from occasional leaks to a complete inability to control urination. This condition can be caused by various factors, including weakened pelvic floor muscles, hormonal changes, obesity, neurological conditions, urinary tract infections, certain medications, and pregnancy.

The primary categories of urinary incontinence include urge incontinence, stress incontinence, overflow incontinence, and functional incontinence. Urge incontinence, also known as overactive bladder, is typified by a sudden and intense urge to urinate that is difficult to control. This type is typically managed through medications that help calm and control bladder muscles, along with behavioral techniques such as bladder training and lifestyle adjustments. Various treatments, including medications and medical devices, are administered through oral, parenteral, and other routes to address urinary incontinence. Diagnostic tools and services, such as physical examinations, pad tests, urodynamic testing, cystoscopy, stress tests, ultrasound scans, and urine samples, are provided by a range of end users, including hospitals, specialty clinics, homecare services, and others.

The urinary incontinence market research report is one of a series of new reports from The Business Research Company that provides urinary incontinence market statistics, including urinary incontinence industry global market size, regional shares, competitors with a urinary incontinence market share, detailed urinary incontinence market segments, market trends and opportunities and any further data you may need to thrive in the urinary incontinence industry. This urinary incontinence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinary incontinence market size has grown strongly in recent years. It will grow from $11.61 billion in 2023 to $12.52 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to aging population, awareness of urinary incontinence, rising prevalence of urinary incontinence, increasing access to healthcare, rising disposable incomes.

The urinary incontinence market size is expected to see strong growth in the next few years. It will grow to $16.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of comorbidities, lifestyle factors, population health strategies, growing healthcare expenditures. Major trends in the forecast period include medical advancements, innovative technologies, non-invasive treatments, digital health and mhealth, innovative product designs, patient-centered care.

The increasing prevalence of urological disorders is set to provide significant impetus to the expansion of the urinary incontinence market in the near future. Urological disorders encompass a wide array of medical conditions affecting the urinary system and male reproductive organs, which includes critical components like the kidneys, bladder, ureters, urethra, prostate, and testes. This upsurge in the prevalence of urological disorders, with a particular emphasis on conditions like urinary incontinence, is driving the demand for products and treatment options designed to address these healthcare concerns. The rising awareness and diagnosis of urological disorders, in conjunction with ongoing developments in medical solutions and healthcare infrastructure, are further bolstering the growth of this market. For instance, recent data from January 2023, as reported by the American Cancer Society Inc., reveals that the estimated cases of urinary bladder cancer in the United States have reached 82,290 in 2023, signifying a 1.1% increase from the 81,400 cases recorded in 2020. This underscores the momentum behind the expansion of the urinary incontinence market, primarily driven by the growing incidence of urological disorders.

The increasing demand for minimally invasive procedures is anticipated to be a driving force for the growth of the urinary incontinence market in the foreseeable future. Minimally invasive procedures encompass surgical techniques and interventions that involve the utilization of specialized instruments and advanced technology to reduce the size and quantity of incisions required during surgery. This heightened demand for minimally invasive procedures plays a crucial role in managing urinary incontinence, offering an effective and patient-friendly approach to its treatment. Patients and healthcare providers are increasingly opting for these methods to address the condition while minimizing the impact on a patient's daily life and overall well-being. For instance, as of January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicate that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022. This reflects an impressive 18% increase compared to the approximately 1,594,000 procedures conducted with Vinci Surgical Systems in 2021. Therefore, the mounting demand for minimally invasive procedures is set to be a significant driver behind the growth of the urinary incontinence market.

The main challenge hindering the growth of the urinary incontinence market during the forecast period is the limited accessibility of effective mechanical devices for urinary incontinence. This restricted availability of reliable mechanical devices for urinary incontinence proves to be a significant impediment in the market. It can lead to a lower number of individuals seeking treatment and can result in dissatisfaction with treatment outcomes. For instance, a Health Affairs article from 2021 reported that the United States experienced at least one shortage of medical devices each year, with the highest frequency occurring in 2020. Consequently, the limited accessibility of effective mechanical devices for urinary incontinence is constraining the expansion of the urinary incontinence market.

Prominent companies within the urinary incontinence market are proactively adopting cutting-edge technologies and groundbreaking approaches to elevate patient care and enhance treatment outcomes. For instance, in July 2023, UroMems SAS, a biotechnology firm based in France, successfully carried out the implantation of the UroActive smart artificial urinary sphincter (AUS) in a female patient for the treatment of stress urinary incontinence (SUI) in women. This groundbreaking UroActive device is powered by a myoelectrical mechanical system (MEMS) meticulously engineered to address the unmet need for a definitive SUI treatment in women. The procedure was conducted with robotic assistance at La Pitie-Salpetriere University Hospital in Paris and garnered regulatory approval from the French equivalent of the FDA. UroActive's adaptability, intelligent functionality, and minimally invasive approach collectively aim to enhance the quality of life for patients.

In February 2021, Axonics Modulation Technologies, Inc., a US-based medical equipment manufacturing company, acquired Contura Ltd. for $200 million. The acquisition of Contura Ltd. allowed Axonics Modulation Technologies to expand its offerings, enhance its value proposition to customers and leverage its existing commercial footprint to address the underpenetrated stress urinary incontinence (SUI) market with a clinically differentiated solution. Contura Ltd. is a UK-based medical technology company specializing in developing urinary health treatment products.

Major players in the urinary incontinence market are Cardinal Health Inc., Johnson and Johnson, Medtronic PLC, Eli Lilly and Company, Asahi Kasei Corporation, Becton Dickinson and Company (C.R. Bard Inc.), Teva Pharmaceutical Industries Ltd., Berry Global Inc., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Domtar Corporation, Cook Medical Inc., Aurobindo Pharma Ltd., Coloplast AIS, Teleflex Incorporated, Apotex Inc., Zydus Lifesciences Limited, ConvaTec Group PLC, Cook Group Inc., Torrent Pharmaceuticals Ltd., Alennbic Pharmaceuticals Limited, Laborie Medical Technologies Corp., NeoTract Inc., Ethicon Inc., Promedon GmbH, Caldera Medical Inc .

North America was the largest region in the urinary incontinence market in 2023. The regions covered in urinary incontinence report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urinary incontinence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urinary incontinence market includes revenues earned by entities by providing medical diagnosis and evaluation, medication and surgical interventions, pelvic floor muscle training and physical therapy, behavioral therapies and bladder training and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The urinary incontinence market also includes sales of electrical stimulation devices, foley catheters, antimicrobial foley catheters and urethral bulking agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Urinary Incontinence Market Characteristics

3. Urinary Incontinence Market Trends And Strategies

4. Urinary Incontinence Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Urinary Incontinence Market Size and Growth

  • 5.1. Global Urinary Incontinence Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Urinary Incontinence Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Urinary Incontinence Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Urinary Incontinence Market Segmentation

  • 6.1. Global Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Urge Incontinence
  • Stress Incontinence
  • Overflow Incontinence
  • Functional Incontinence
  • 6.2. Global Urinary Incontinence Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medication
  • Devices
  • Other Treatments
  • 6.3. Global Urinary Incontinence Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes Of Administrations
  • 6.4. Global Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Physical Exam
  • Pad Test
  • Urodynamic Testing
  • Cystoscopy
  • Stress Test
  • Ultrasound
  • Urine Samples
  • 6.5. Global Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Urinary Incontinence Market Regional And Country Analysis

  • 7.1. Global Urinary Incontinence Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Urinary Incontinence Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Urinary Incontinence Market

  • 8.1. Asia-Pacific Urinary Incontinence Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Urinary Incontinence Market

  • 9.1. China Urinary Incontinence Market Overview
  • 9.2. China Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Urinary Incontinence Market

  • 10.1. India Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Urinary Incontinence Market

  • 11.1. Japan Urinary Incontinence Market Overview
  • 11.2. Japan Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Urinary Incontinence Market

  • 12.1. Australia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Urinary Incontinence Market

  • 13.1. Indonesia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Urinary Incontinence Market

  • 14.1. South Korea Urinary Incontinence Market Overview
  • 14.2. South Korea Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Urinary Incontinence Market

  • 15.1. Western Europe Urinary Incontinence Market Overview
  • 15.2. Western Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Urinary Incontinence Market

  • 16.1. UK Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Urinary Incontinence Market

  • 17.1. Germany Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Urinary Incontinence Market

  • 18.1. France Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Urinary Incontinence Market

  • 19.1. Italy Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Urinary Incontinence Market

  • 20.1. Spain Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Urinary Incontinence Market

  • 21.1. Eastern Europe Urinary Incontinence Market Overview
  • 21.2. Eastern Europe Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Urinary Incontinence Market

  • 22.1. Russia Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Urinary Incontinence Market

  • 23.1. North America Urinary Incontinence Market Overview
  • 23.2. North America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Urinary Incontinence Market

  • 24.1. USA Urinary Incontinence Market Overview
  • 24.2. USA Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Urinary Incontinence Market

  • 25.1. Canada Urinary Incontinence Market Overview
  • 25.2. Canada Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Urinary Incontinence Market

  • 26.1. South America Urinary Incontinence Market Overview
  • 26.2. South America Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Urinary Incontinence Market

  • 27.1. Brazil Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Urinary Incontinence Market

  • 28.1. Middle East Urinary Incontinence Market Overview
  • 28.2. Middle East Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Urinary Incontinence Market

  • 29.1. Africa Urinary Incontinence Market Overview
  • 29.2. Africa Urinary Incontinence Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Urinary Incontinence Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Urinary Incontinence Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Urinary Incontinence Market Competitive Landscape And Company Profiles

  • 30.1. Urinary Incontinence Market Competitive Landscape
  • 30.2. Urinary Incontinence Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eli Lilly and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Asahi Kasei Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Urinary Incontinence Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (C.R. Bard Inc.)
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Berry Global Inc.
  • 31.4. Boston Scientific Corporation
  • 31.5. Mylan N.V.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Domtar Corporation
  • 31.8. Cook Medical Inc.
  • 31.9. Aurobindo Pharma Ltd
  • 31.10. Coloplast AIS
  • 31.11. Teleflex Incorporated
  • 31.12. Apotex Inc.
  • 31.13. Zydus Lifesciences Limited
  • 31.14. ConvaTec Group PLC
  • 31.15. Cook Group Inc.

32. Global Urinary Incontinence Market Competitive Benchmarking

33. Global Urinary Incontinence Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Urinary Incontinence Market

35. Urinary Incontinence Market Future Outlook and Potential Analysis

  • 35.1 Urinary Incontinence Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Urinary Incontinence Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Urinary Incontinence Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer